Next Generation News and Research

RSS

Betaretrovirus may infect patients with primary biliary cirrhosis

In a new study published in Alimentary Pharmacology & Therapeutics, researchers at the University of Alberta's Faculty of Medicine & Dentistry have shown that a betaretrovirus which resembles a mouse mammary tumor virus infects patients with the rare liver disease, primary biliary cirrhosis (PBC).

20 Feb 2015

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

The international outbreak of Ebola in 2014 serves as a reminder for the need to be proactive in preparing for the rapid spread of any newly emerging or re-emerging infectious disease. IDRI today announces it has received $4 million in funding from the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to facilitate pandemic influenza preparedness in developing countries.

19 Feb 2015

New doctorate program to study substance use and related social, health consequences

A new Joint Doctoral Program (JDP) in Interdisciplinary Research on Substance Use has been launched by the Division of Global Public Health in the University of California, San Diego School of Medicine and San Diego State University's School of Social Work. The program will emphasize research devoted to studying the use and misuse of alcohol and drugs - and related social and health consequences.

19 Feb 2015

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand--the first study to demonstrate that a vaccine can protect people from HIV infection.

19 Feb 2015

TB Alliance announces initiation of first human trial of new TB drug candidate

TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB drug candidate to begin a Phase 1 clinical trial since 2009.

19 Feb 2015

Sigma-Aldrich announces release of Next-Gen Sequencing Oligos

Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly.

18 Feb 2015

Caris Life Sciences announces record-setting revenue for 2014

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced select year-end financial and operational results for 2014, which include record-setting revenue and continued case volume growth for its panomic, comprehensive tumor profiling service, Caris Molecular Intelligence.

18 Feb 2015

Cabazitaxel therapy may be more effective in treating prostate cancer

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.

17 Feb 2015

POCARED Diagnostics announces closure of another $15M in funding

POCARED Diagnostics Ltd. is an Israeli-based Diagnostics and Pre-analytical technology manufacturer with offices in the United States announced they have closed another $15 Million in funding.

17 Feb 2015

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

In recent months, several national initiatives for personalized medicine have been announced, including the recently launched precision medicine initiative in the US, driven by rapid advances in genomic technologies and with the promise of cheaper and better healthcare. Significant challenges remain, however, in the management and analysis of genetic information and their integration with patient data.

15 Feb 2015

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.

11 Feb 2015

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.

From Quest Diagnostics 10 Feb 2015

Study shows preeclampsia and low birth weight reoccur in the next generation

In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.

9 Feb 2015

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new "Program in Lung Healing," that will further the School's position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.

9 Feb 2015

CVS Health Foundation announces $5 million commitment to campaign for tobacco-free kids

The CVS Health Foundation today announced a $5 million five-year commitment to the Campaign for Tobacco-Free Kids to launch its new "Making the Next Generation Tobacco-Free" grant program.

6 Feb 2015

Joyce and Don Massey Family Foundation supports U-M’s TBI care and research

A tragic accident 32 years ago forever altered the lives of an entire prominent Michigan auto industry family, as a beloved wife and mother suffered a devastating traumatic brain injury, or TBI.

6 Feb 2015

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, finding novel ways to treat immune disorders and blood diseases and developing a new animal model for exploring diseases like heart failure, diabetes and neurodegenerative diseases.

5 Feb 2015

Welch Allyn partners with Nonin Medical to provide clinically-proven PureSAT SpO2 technology

Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today announced it has partnered with Nonin Medical, a leader in designing and manufacturing noninvasive medical monitoring solutions, to provide its clinically-proven PureSAT SpO2 technology.

4 Feb 2015

Parents can pass silenced genes to offspring through a specific mechanism

For more than a century, scientists have understood the basics of inheritance: if good genes help parents survive and reproduce, the parents pass those genes along to their offspring. And yet, recent research has shown that reality is much more complex: genes can be switched off, or silenced, in response to the environment or other factors, and sometimes these changes can be passed from one generation to the next.

4 Feb 2015

TMM journal reviews latest advances in reproductive medicine

The journal Trends in Molecular Medicine reviews the latest advances in reproductive medicine--from mitochondrial replacement therapy to the infant microbiome--with a special issue on "Nurturing the Next Generation," published February 3, 2015.

4 Feb 2015

Next Generation News and Research

Betaretrovirus may infect patients with primary biliary cirrhosis

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

New doctorate program to study substance use and related social, health consequences

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

TB Alliance announces initiation of first human trial of new TB drug candidate

Sigma-Aldrich announces release of Next-Gen Sequencing Oligos

Caris Life Sciences announces record-setting revenue for 2014

Cabazitaxel therapy may be more effective in treating prostate cancer

POCARED Diagnostics announces closure of another $15M in funding

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Study shows preeclampsia and low birth weight reoccur in the next generation

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

CVS Health Foundation announces $5 million commitment to campaign for tobacco-free kids

Joyce and Don Massey Family Foundation supports U-M’s TBI care and research

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Welch Allyn partners with Nonin Medical to provide clinically-proven PureSAT SpO2 technology

Parents can pass silenced genes to offspring through a specific mechanism

TMM journal reviews latest advances in reproductive medicine

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News